These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9346456)

  • 21. [Prospective evaluation of prostate cancer screening in men with a family history of the disease].
    Paiss T; Herkommer K; Kahn D; Gschwend JE; Küfer R; Maier C; Vogel W; Högel J; Hautmann RE
    Urologe A; 2006 Aug; 45(8):1002-5. PubMed ID: 16830128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lest we abandon digital rectal examination as a screening test for prostate cancer.
    Basler JW; Thompson IM
    J Natl Cancer Inst; 1998 Dec; 90(23):1761-3. PubMed ID: 9839511
    [No Abstract]   [Full Text] [Related]  

  • 23. Final results of a screening campaign for prostate cancer.
    Martín E; Luján M; Sánchez E; Herrero A; Páez A; Berenguer A
    Eur Urol; 1999 Jan; 35(1):26-31. PubMed ID: 9933791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer screening and mortality: a case-control study (United States).
    Weinmann S; Richert-Boe K; Glass AG; Weiss NS
    Cancer Causes Control; 2004 Mar; 15(2):133-8. PubMed ID: 15017125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case-control study of screening for prostatic cancer by digital rectal examinations.
    Friedman GD; Hiatt RA; Quesenberry CP; Selby JV
    Lancet; 1991 Jun; 337(8756):1526-9. PubMed ID: 1675379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The diagnostic value of digital rectal examination in primary care screening for prostate cancer: a meta-analysis.
    Hoogendam A; Buntinx F; de Vet HC
    Fam Pract; 1999 Dec; 16(6):621-6. PubMed ID: 10625141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Pinsky PF; Blacka A; Kramer BS; Miller A; Prorok PC; Berg C
    Clin Trials; 2010 Aug; 7(4):303-11. PubMed ID: 20571134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percent free PSA as an additional measure in a prostate cancer screen.
    Miele ME
    Clin Lab Sci; 2001; 14(2):102-7. PubMed ID: 15625982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate cancer screening.
    Roetzheim RG; Herold AH
    Prim Care; 1992 Sep; 19(3):637-49. PubMed ID: 1384077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Local screening program for prostate cancer].
    Kotsev R; Kolev N; Stratev S; Mikhailov O
    Khirurgiia (Sofiia); 2000; 56(5-6):52-4. PubMed ID: 11692936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer screening at an equal access tertiary care center: its impact 10 years after the introduction of PSA.
    Soderdahl DW; Hernandez J
    Prostate Cancer Prostatic Dis; 2002; 5(1):32-5. PubMed ID: 15195128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for prostate cancer: are digital rectal examinations being performed?
    Federman DG; Pitkin P; Carbone V; Concato J; Kravetz JD
    Hosp Pract (1995); 2014 Apr; 42(2):103-7. PubMed ID: 24769789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer: who to screen, and what the results mean.
    Small EJ
    Geriatrics; 1993 Dec; 48(12):28-30, 35-8. PubMed ID: 7504646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project.
    Mettlin C; Murphy GP; Babaian RJ; Chesley A; Kane RA; Littrup PJ; Mostofi FK; Ray PS; Shanberg AM; Toi A
    Cancer; 1996 Jan; 77(1):150-9. PubMed ID: 8630923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Screening of cancer of the prostate: study in a Spanish population].
    Herrero Payo JA; Montes Díaz MJ; Páez Borda A; Sánchez Sánchez E; Moreno Valle JA; Berenguer Sánchez A
    Arch Esp Urol; 1996; 49(6):595-606. PubMed ID: 8929102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer association studies: pitfalls and solutions to cancer misclassification in the PSA era.
    Platz EA; De Marzo AM; Giovannucci E
    J Cell Biochem; 2004 Feb; 91(3):553-71. PubMed ID: 14755685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An analysis of digital rectal examination and serum-prostate-specific antigen in the early detection of prostate cancer in general practice.
    Brett TD
    Fam Pract; 1998 Dec; 15(6):529-33. PubMed ID: 10078792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Digital rectal examination and the diagnosis of prostate cancer--a study based on 8 years and three screenings within the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam.
    Gosselaar C; Roobol MJ; van den Bergh RC; Wolters T; Schröder FH
    Eur Urol; 2009 Jan; 55(1):139-46. PubMed ID: 18406045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng/ml and nonsuspicious results of digital rectal examination.
    Karazanashvili G; Managadze L
    Eur Urol; 2001 May; 39(5):538-43. PubMed ID: 11464034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.